0001722024-20-000014.txt : 20200915
0001722024-20-000014.hdr.sgml : 20200915
20200915180604
ACCESSION NUMBER: 0001722024-20-000014
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200915
DATE AS OF CHANGE: 20200915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC
CENTRAL INDEX KEY: 0001722024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39512
FILM NUMBER: 201176913
BUSINESS ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
BUSINESS PHONE: 626-578-0777
MAIL ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Metacrine, Inc.
CENTRAL INDEX KEY: 0001634379
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472297384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-369-7800
MAIL ADDRESS:
STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
wf-form3_160020754820938.xml
FORM 3
X0206
3
2020-09-15
0
0001634379
Metacrine, Inc.
MTCR
0001722024
Alexandria Venture Investments, LLC
26 NORTH EUCLID AVENUE
PASADENA
CA
91101
0
0
1
0
Series A convertible preferred stock
Common stock
901960.0
D
Series B convertible preferred stock
Common stock
217235.0
D
Series C convertible preferred stock
Common stock
149600.0
D
The preferred stock is convertible into the Issuer's common stock at a ratio of 5.1 shares of preferred stock to 1 share of common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering, for no additional consideration.
By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member
By: /s/ Dean A. Shigenaga
Chief Financial Officer
2020-09-15